Aortoiliac embolism
ICD-10 I74.5 · ICD-11 BD30.10

What is the first-line treatment for Aortoiliac embolism?

Aortoiliac embolism is an acute vascular emergency. Prompt initial treatment is required to stabilise the patient and protect limb viability while definitive revascularisation is arranged.

Initial Management
First-line management centres on immediate systemic anticoagulation with intravenous unfractionated heparin, combined with essential supportive interventions administered while the patient awaits revascularisation. The complete anticoagulation regimen — including dosing, monitoring parameters, and the full supportive care protocol — is specified in the structured evidence-based guideline.
Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.ejvs.2019.09.006

Initial medical treatment of ALI includes appropriate analgesia and intravenous administration of unfractionated heparin (UFH): initially 5 000 IU, or 70–100 IU/kg, followed by infusion, dose adjusted to patient response, and monitored by activated clotting time or activated partial thromboplastin time (APTT).

For patients with acute limb ischaemia awaiting revascularisation, heparin is recommended.

For patients with acute limb ischaemia awaiting revascularisation, supplemental oxygen is recommended.

For patients with acute limb ischaemia awaiting revascularisation, adequate analgesia and intravenous rehydration are recommended.

View source ↗